The Slow Build: How Equity Concentration Quietly Reshapes Career Decisions  Lessons from the Road  The short answer  Golden handcuffs are the unvested equity, deferred compensation and retention awards that make leaving a company expensive. For pharma and biotech executives, they rarely arrive all at once. They build award by award over years of good performance, […]